Introduction {#Sec1}
============

Eosinophilic esophagitis (EoE) is a chronic antigen-mediated allergic disease of the esophagus in adults and children \[[@CR1]--[@CR3]\]. EoE is commonly found in Western countries but is relatively rare in Asia \[[@CR4], [@CR5]\]; nevertheless, the prevalence of EoE has been increasing in Japan \[[@CR6]--[@CR8]\]. Recent European guidelines \[[@CR2]\] and International consensus (AGREE) \[[@CR3]\] have demonstrated that the diagnostic criteria of EoE include the presence of esophageal symptoms and esophageal eosinophil (eos) infiltration, defined as intraepithelial eosinophil infiltration of ≥ 15 eos/high-power field (hpf). Although the diagnosis of EoE is not clinically challenging, several important issues require consideration in the diagnostic approach. Most patients in Western countries complain of typical symptoms such as dysphagia and food impaction \[[@CR9], [@CR10]\]; however, the prevalence of symptom variations in Japanese adult patients with EoE has not yet been elucidated. The current study analyzed the prevalence of symptoms in Japanese patients with EoE, categorized the symptoms, provided a review of the diagnostic approach, briefly explained the current therapeutic strategies, and finally proposed a symptom-based diagnostic approach. Although the current criteria require the presence of esophageal symptoms \[[@CR1]--[@CR3]\], asymptomatic cases have been reported in Japan, particularly during medical examinations \[[@CR11]--[@CR14]\]. Therefore, asymptomatic cases, formally known as "asymptomatic esophageal eosinophilia," have been included in this review as asymptomatic EoE.

Prevalence of symptom variations {#Sec2}
================================

Clinical studies and case reports of EoE in Japanese adults were identified by searching PubMed, Ichushi, Shoreikun, and UMIN in February 2020. Relevant articles were identified using terms "Japanese" or "Japan" and "eosinophilic esophagitis" or "esophageal eosinophilia". Articles and abstracts of pediatric cases as well as basic studies using animals or cell lines were excluded. Clinical studies or case reports and abstracts of case reports or case series that included clinical symptoms and their prevalence were selected. Overall, 53 full articles, including 31 case reports \[[@CR11]--[@CR63]\] and 60 abstracts (in Japanese), were collected and reviewed. The symptoms were divided into three categories as follows: (1) typical symptoms, such as dysphagia and food impaction; (2) other upper GI symptoms, such as heartburn, acid regurgitation, chest pain, epigastralgia and abdominal pain, nausea or vomiting, globus sensation, odynophagia, and anorexia; and (3) no symptoms found incidentally during screening or medical examinations.

The analysis of 886 cases is shown in Table [1](#Tab1){ref-type="table"}. Typical symptoms, such as dysphagia or food impaction, were observed in 469 (52.9%) cases, whereas heartburn or acid regurgitation was noted in 224 (25.3%), chest pain in 59 (6.7%), epigastralgia or abdominal pain in 42 (4.7%), other symptoms in 38 (4.3%), and no symptoms in 167 (18.8%) cases. Figure [1](#Fig1){ref-type="fig"} shows the proportion of symptoms according to the symptom categories of EoE in Japanese patients. Typical symptoms were found in 41.2% of cases, other upper GI symptoms were found in 28.3%, both symptoms were found in 11.7%, and no symptoms were found in 18.8%. Western studies have shown that dysphagia (70--80%) and food impaction (33--54%) constitute the most common symptoms of adult EoE \[[@CR2], [@CR9], [@CR10]\]. The present study showed similar results, but the prevalence of typical symptoms was lower than that observed in Western countries. Dellon et al. analyzed the symptoms of 151 adults with EoE and reported the presence of dysphagia (73%), food impaction (30%), heartburn (42%), chest pain (8%), and abdominal pain (26%) \[[@CR9]\], suggesting that the prevalence of heartburn and abdominal pain in Japanese patients with EoE was low: when EoE patients with symptoms were analyzed, prevalence of dysphagia/food impaction, heartburn/acid regurgitation, chest pain, and epigastralgia/abdominal pain was 65.2%, 31.2%, 8.2%, and 5.8%, respectively.Table 1Prevalence of symptoms of eosinophilic esophagitis in Japanese adultsAuthor \[Ref\]Number of casesDysphagia food impactionHeartburn/acid regurgitationChest pain/chest discomfortEpigastralgia/Abdominal painOthers symptoms\*Other upper GI symptoms\*\*No symptomsAbe et al. \[[@CR15]\]127112043Fujishiro et al. \[[@CR16]\]72202040Fujiwara et al. \[[@CR17]\]73300031Kinoshita et al.\[[@CR18]\]261220013150Tomomatsu et al.\[[@CR19]\]106310040Hori et al. \[[@CR20]\]52000112Abe et al. \[[@CR15]\]101200028Shimura et al. \[[@CR22]\]125411064Kusunose et al.\[[@CR23]\]138601070Iwakura et al. \[[@CR24]\]33306400100Ishimura et al. \[[@CR25]\]43200020Jiao et al. \[[@CR26]\]271513405220Okimoto et al. \[[@CR27]\]7037220130359Okimoto et al. \[[@CR28]\]62301040Adachi et al. \[[@CR11]\]3617121101411Sato et al. \[[@CR12]\]175500057Ishimura et al. \[[@CR29]\]553118000180Ishimura et al. \[[@CR30]\]147765216006825Sawada et al. \[[@CR31]\]106732716004312Takashima et al. \[[@CR32]\]2719100017Tanaka et al. \[[@CR13]\]2719100017Ishibashi et al. \[[@CR14]\]3700000037Case reports\#39203556178Abstracts\#\#15376361016136826Total886469224594238354167Prevalence100%52.9%25.3%6.7%4.7%4.3%40.0%18.8%Patients with symptoms719469224594238354Prevalence\#\#\#100%65.2%31.2%8.2%5.8%5.3%49.2%\*Other symptoms include nausea/vomiting, globus sensation, anorexia, odynophagia, and belching\*\* Number of other upper GI symptoms is the incidence of heartburn/acid regurgitation, chest pain/discomfort, epigastralgia/abdominal pain, and other symptoms\# Summary of 31 full articles of case reports\#\# Summary of 70 abstracts of case reports and series\#\#\# prevalence calculated in patients with symptomsFig. 1Proportion of symptoms in Japanese adults with eosinophilic esophagitis. Symptoms were divided into typical symptoms (such as dysphagia and food impaction), other upper GI symptoms (such as heartburn, epigastralgia, and chest pain), and no symptoms

Further, seven case series and 91 case reports and abstracts describing patient age and sex were collected. Finally, 131 patient cases (91 men and 40 women; mean age, 49.8 years) were analyzed in detail according to age and sex. In this review, patient ages were divided into 3 groups as follows: young (20--39 years), middle (40--69), and elderly (≥ 70 years). Among the 131 cases, 34 were young, 80 were middle-aged, and 17 were elderly. Figure [2](#Fig2){ref-type="fig"} shows the prevalence of various symptoms according to the age group. Dysphagia or food impaction was the most common symptom across the age groups. There was a significant increase in the incidence of chest pain or discomfort in the middle-aged group and in the incidence of anorexia in the elderly, as determined using Chi-square test. However, there were no significant differences in the other symptoms, such as reflux symptoms and epigastralgia, among the age groups. Some differences in symptom patterns among age groups were observed between Western and Japanese patients. Indeed, Dellon et al. showed that other upper GI symptoms were observed in younger patients, whereas typical symptoms were primarily observed in comparatively older patients \[[@CR9]\]. There were no sex differences in relation to the prevalence of symptoms (dysphagia 65.9% in men and 62.5% in women, heartburn/regurgitation 25.3% in men and 27.5% in women, epigastralgia/abdominal pain 8.8% in men and 17.5% in women, chest pain/discomfort 14.3% in men and 20.0% in women, nausea/vomiting 3.3% in men and 5.0% in women, globus 3.3% in men and 0% in women, anorexia 2.2% in men and 2.5% in women, and odynophagia 0% in men and 2.5% in women). These results suggest that in the diagnosis of EoE, physicians should pay close attention to chest pain in middle-aged patients and anorexia in elderly patients. Moreover, we demonstrated that dysphagia/food impaction, heartburn/acid regurgitation, and epigastralgia/abdominal pain are common symptoms in Japanese patients with EoE although food impaction requiring emergency endoscopy is uncommon in Japan.Fig. 2Prevalence of various symptoms in Japanese adults with eosinophilic esophagitis according to age group, Chest pain or discomfort was significantly more common in the middle-aged group, and anorexia was significantly more common in the elderly group. The prevalence of other symptoms was similar among the age groups (\**p* \< 0.01)

Diagnostic approach-1 {#Sec3}
=====================

The diagnostic approach was described according to symptom categories.

Typical symptoms {#Sec4}
----------------

Dysphagia and food impaction are caused by several diseases; in particular, esophageal cancers, gastroesophageal reflux disease (GERD), and achalasia are important and should be excluded. Several guidelines have proposed that biopsies should be obtained in cases where EoE is suspected from symptoms regardless of endoscopic findings \[[@CR1]--[@CR3]\]. European guidelines state that at least six biopsies should be performed from different locations, focusing on areas with endoscopic mucosal abnormalities \[[@CR2]\]. Moreover, the American College of Gastroenterology guidelines strongly recommends that 2--4 biopsies should be obtained from both the proximal and distal esophagus \[[@CR1]\]. In our previous study \[[@CR64]\], two biopsies each from the lower and middle esophagus revealed a high diagnostic accuracy rate. Therefore, multiple biopsies (4--6) should be recommended in patients with typical symptoms.

Typical endoscopic findings include edema, rings, exudates, furrows, and strictures \[[@CR1]--[@CR3]\] (Fig. [3](#Fig3){ref-type="fig"}). The endoscopic findings were graded by the Endoscopic Reference Score System (ERERS) as follows: edema (0, absent; 1, present); rings (0, none; 1, mild; 2, moderate; 3, severe); exudates \[0, none; 1, mild (\< 10% of the esophageal surface area); 2, severe (\> 10% of the esophageal surface area)\]; furrows (0, absent; 1, present); and strictures (0, absent; 1, present) \[[@CR65]\]. Although fibrostenotic cases with rings or strictures are clinically problematic and common in Western countries \[[@CR66]\], grade 3 rings and grade 1 strictures are currently rare in Japanese patients. Although Japanese endoscopists prefer endoscopic diagnosis, there are several important issues with regard to such diagnosis of EoE. First, Izumi et al. reported that the inter-observer agreement on the endoscopic diagnosis of EoE among Japanese endoscopists was low and revealed that the kappa coefficient of reliability was 0.34 (0.33--0.35) \[[@CR67]\]. Second, three previous studies have shown that the prevalence of esophageal eosinophilia on biopsy in cases with typical endoscopic EoE findings was low (11.1--30.8%) \[[@CR20], [@CR22], [@CR68]\]. This is related to the international diagnostic criteria that do not include endoscopic findings. Third, although several guidelines have proposed multiple biopsies of normal esophageal mucosal appearance in cases suspicious of EoE \[[@CR1], [@CR3]\], a Japanese multicenter study only found 1 such case (0.34%) in a total of 289 cases \[[@CR22]\].Fig. 3Endoscopic appearance of eosinophilic esophagitis. **a** Edema, grade 1. **b** Rings, grade 1. **c** Furrows, grade 1. **d** Exudates, grade 2. **e** Stricture, grade 1. **f** Normal appearance. Endoscopic grading was performed according to the EREFS score system

The aforementioned reports emphasize the importance of multiple biopsies in patients with typical symptoms. Indeed, multiple biopsies are the only modality that can exclude EoE when no significant esophageal eosinophilia is observed. Rome IV criteria suggest that exclusion of EoE is necessary for the diagnosis of functional dysphagia \[[@CR69]\].

Other upper GI symptoms {#Sec5}
-----------------------

A similar diagnostic strategy to that illustrated above is adapted in patients with other upper GI symptoms, such as heartburn, acid regurgitation, epigastralgia, abdominal pain, nausea, vomiting, chest pain, and globus sensation. However, in cases with endoscopically normal esophageal appearance, multiple biopsies should be limited when patients are refractory to the standard treatment. EoE is one of the causes of proton pump inhibitor (PPI)-refractory GERD \[[@CR70]\]. Kawami et al. analyzed 53 cases with double doses of PPI-resistant nonerosive reflux disease, defined as the presence of reflux symptoms without esophageal mucosal breaks, and found only 1 (1.9%) case of EoE \[[@CR71]\]. Furthermore, Okimoto et al. performed multiple biopsies of the esophagus in 62 patients with PPI-refractory GERD. They found 6 (9.7%) cases with EoE, five of which had an endoscopically normal esophageal appearance \[[@CR28]\].

The exact prevalence of EoE among PPI-refractory GERD in Japanese patients is unknown; thus, a large multicenter study is required. Finally, it is necessary to obtain multiple biopsies because the exclusion of EoE is one of the diagnostic criteria of functional heartburn, reflux hypersensitivity, functional chest pain, and globus according to the Rome IV criteria \[[@CR69]\].

Medical health examinations {#Sec6}
---------------------------

The local government or employer provides annual medical examinations for inhabitants and employers in Japan. Because cancer screening programs, particularly for gastric cancer, are widely accepted in Japan, EoE is often incidentally found during esophagogastroduodenoscopy (EGD). Several studies have shown that the prevalence of EoE among individuals who underwent annual medical examination ranged from 0.06 to 0.47% \[[@CR11]--[@CR14]\]. However, whether biopsies should be obtained in cases with EoE endoscopic findings observed in medical examinations remains debatable because the positive rate of esophageal eosinophilia in cases with EoE endoscopic findings is low \[[@CR20], [@CR22], [@CR68]\] and because most individuals who undergo medical examinations are healthy or have mild or no symptoms. Minimal target biopsies can be recommended in such cases for the following two reasons. First, it is difficult to perform a detailed medical interview for EoE before and during endoscopy. Although Ishibashi et al. reported that all 37 cases of EoE found in medical examinations were asymptomatic \[[@CR14]\], 3 other studies showed that 64--74% of the EoE cases found in medical examinations had symptoms \[[@CR11]--[@CR13]\]. Although some symptoms were mild, others required treatment. Second, studies conducted in Western countries have suggested that untreated EoE is associated with persistent symptoms and inflammation, leading to esophageal remodeling and a fibrostenotic phenotype \[[@CR2]\].

The natural history of Japanese EoE, especially asymptomatic EoE, has not yet been completely elucidated. Ishibashi et al. demonstrated that 18 (62.1%) of 29 cases with asymptomatic EoE developed progressive diseases, including six cases with symptomatic EoE and 12 cases with endoscopic exacerbation \[[@CR14]\]. Sato et al. showed that most cases with asymptomatic EoE showed a slow progression as observed on chronological endoscopic analysis \[[@CR12]\]. Therefore, biopsies might be necessary to examine the natural history of Japanese patients with asymptomatic EoE. Adachi et al. showed that significant esophageal eosinophilia could be detected by biopsies on the lower esophagus as well as by the presence of exudates \[[@CR72]\]. In summary, target biopsies are recommended in cases that are endoscopically suspicious of EoE during medical examinations, particularly in cases with any mild symptoms or severe endoscopic findings that might be associated with a fibrostenotic phenotype. Furthermore, in asymptomatic EoE cases, it is not always necessary to perform a biopsy. Another option is to refer to a high-volume center for re-examination of endoscopy with multiple biopsies.

Diagnostic approach-2 {#Sec7}
=====================

Diagnosis after biopsy examination according to the presence or absence of esophageal eosinophilia has been discussed.

Esophageal eosinophilia {#Sec8}
-----------------------

All cases with esophageal eosinophilia, defined as ≥ 15 eos/hpf (\~ 60 eos/mm^2^), involve differential diagnoses, such as GERD, eosinophilic gastroenteritis, achalasia, viral or fungal infection, autoimmune diseases, skin diseases, drug-induced esophagitis, Crohn disease, and graft versus host disease \[[@CR1]--[@CR3]\]. Most cases can be differentiated from EoE via physical examination, blood tests, endoscopic appearance, and other diagnostic modalities. Nevertheless, the association between GERD and EoE remains controversial because PPI therapy has improved both diseases \[[@CR2], [@CR3]\] and because GERD is a common disease affecting 10--20% of Japanese adults \[[@CR73]\] and may be overlapped with EoE. However, based on typical EoE endoscopic findings with esophageal eosinophilia on biopsies, the diagnosis of EoE is relatively straightforward.

In differential diagnosis, physicians should pay attention to that some cases of esophageal eosinophilia have similar endoscopic findings of EoE (Fig. [4](#Fig4){ref-type="fig"}). Figure [4](#Fig4){ref-type="fig"}a--c reveals autoimmune esophagitis \[[@CR74]\] and pemphigoid esophagitis without skin manifestations. In such cases, anti-Desmoglein (DSG)-1, anti-DSG-3, or anti-BP180 antibodies may assist in diagnosis. Nakamura et al. analyzed esophageal involvement in 123 autoimmune bullous diseases, and esophageal lesions, such as erosions, blisters, ulcers, and stenoses, were detected in 33 (26.8%) cases. They reported that approximately half of the cases had oral or laryngopharyngeal lesions and that the Nikolsky sign (epidermolysis by mechanical stimulus) is specific for autoimmune bullous diseases \[[@CR75]\]. Figure [4](#Fig4){ref-type="fig"}d shows dabigatran-induced esophagitis, presenting as white exudates on the entire esophageal surface. Moreover, drug history can correctly diagnose EoE, suggesting the importance of medical interviews. Toyo et al. demonstrated that 19 (20.9%) of the 91 patients receiving dabigatran showed esophagitis and that longitudinally sloughing epithelial casts in the middle or lower esophagus was a typical endoscopic finding \[[@CR76]\]. A special type of EoE caused by sublingual immunotherapy (SLIT) for cedar pollinosis is shown in Fig. [4](#Fig4){ref-type="fig"}e, f. Kawashima et al. reported a similar case successfully treated with PPI administration \[[@CR56]\]. In this case, avoiding swallowing medication during SLIT for 2 months improved the patient's symptoms, endoscopic appearance, and histological esophageal eosinophilia. Medications (such as dabigatran and SLIT) and blood tests (such as those with anti-DSG-1, DSG-3, and BP180 antibodies) may help in the differential diagnosis of EoE in some cases.Fig. 4Cases with similar endoscopic appearance of eosinophilic esophagitis and special type of eosinophilic esophagitis. (**a**, **b**) Autoimmune esophagitis. **c** Pemphigoid esophagitis without skin lesions. **d** Dabigatran-induced esophagitis. **e**, **f** EoE caused by sublingual immunotherapy (SLIT). EoE findings (**e**) disappeared after avoiding swallowing medication during SLIT (**f**). NBI images are shown (**e**, **f**)

Absence of esophageal eosinophilia {#Sec9}
----------------------------------

Matsushita et al. analyzed the number of eosinophils in the GI tract of healthy adults and found that normal esophageal eosinophil infiltration was 0.07 ± 0.43 (mean ± SD)/mm^2^, revealing that the normal limit of esophageal eosinophils is 0--1 eos/hpf \[[@CR77]\]. It remains unknown whether cases with the number of esophageal eosinophils between 2 and 14 eos/hpf represent the same condition. It can be considered that cases with ≥ 10 eos/hpf were borderline EoE and require re-evaluation of biopsy specimens and careful follow-up, because patchy eosinophils infiltrate into the esophageal epithelium. Other cases with 2--9 eos/hpf were considered non-allergic, and such cases may be diagnosed as GERD or non-specific esophagitis. Figure [5](#Fig5){ref-type="fig"} shows the concept of the number of esophageal eosinophils being \< 15 eos/hpf. It is necessary to receive re-examination of biopsy or carful follow-up when EoE is highly suspected in case with the absence of esophageal eosinophilia.Fig. 5Concept of eosinophil infiltration in cases without esophageal eosinophilia. Esophageal eosinophilia was defined as ≥ 15 eos/hpf, whereas normal esophagus ranged from 0 to 1 eos/hpf. Eosinophil counts between 2 and 9 eos/hpf were considered as GERD or non-specific esophagitis and those between 10 and 14 eos/hpf were considered borderline esophageal eosinophilia

The diagnosis of cases with the absence of esophageal eosinophilia has been described as a point-by-point discussion.

### On-PPI or off-PPI {#Sec10}

Researchers have carefully assessed cases without esophageal eosinophilia with normal biopsy results and endoscopic findings on PPI therapy \[[@CR3]\]. Odiase et al. reported 2 EoE cases in whom PPI treatment totally obliterated the endoscopic and histologic evidence of EoE. They emphasized that PPI therapy should be discontinued 3--4 weeks before EGD to minimize diagnostic errors of EoE \[[@CR78]\]. Therefore, for strongly suspected EoE cases or cases with persistent symptoms on-PPI therapy, re-evaluation of endoscopy and biopsy examination off-PPI therapy is necessary in some cases without esophageal eosinophilia. In cases with reflux symptoms without strong suspicions of EoE, diagnosis of GERD or PPI-refractory GERD can be made.

### Functional GI disorders (FGIDs) {#Sec11}

Rome IV criteria show the diagnostic criteria of esophageal and gastroduodenal disorders \[[@CR69], [@CR79]\]. Among these, all functional esophageal disorders, including functional chest pain, functional heartburn, reflux hypersensitivity, globus, and functional dysphagia, must be fulfilled with the absence of evidence that EoE is the cause of the symptoms \[[@CR69]\]. In functional dyspepsia, there is no statement regarding EoE \[[@CR79]\]. However, because patients with EoE frequently complain of epigastralgia or abdominal pain, EoE must represent a differential diagnosis, particularly for cases refractory to the standard therapy. Although other diagnostic modalities, such as esophageal high-resolution manometry (HRM) and impedance--pH monitoring, are required according to Rome IV criteria \[[@CR69]\], cases with chest pain, heartburn globus sensation, dysphagia, or epigastralgia could be diagnosed as FGIDs according to symptoms when esophageal eosinophilia is absent.

### EoE-like disease {#Sec12}

Straumann et al. reported 5 cases with EoE-typical and corticosteroid-responsive symptoms without esophageal eosinophilia in 4 EoE families \[[@CR80]\]. They found T-cell infiltration and no increase in eotaxin-3 levels---a key cytokine of EoE---in the esophagus and accordingly proposed a new disease entity \[[@CR80]\]. A recent multicenter study identified 71 patients, of which half were female, 95% reported dysphagia, and 52% were endoscopically active. The study researchers found that the expression of lymphoepithelial Kazal-type-related inhibitor (LEKT1), a protease inhibitor responsible for epithelial homeostasis, was low compared to the control, albeit to a lesser extent than EoE \[[@CR81]\]. Although EoE-like disease is one of the causes of cases with the absence of esophageal eosinophilia, a case of EoE-like disease has not yet been reported in Japan.

### Eosinophilic esophageal myositis {#Sec13}

Eosinophilic esophageal myositis (EoEM) was first reported by Sato \[[@CR82]\] and was associated with Jackhammer esophagus as per the Chicago classification \[[@CR83]\]. EoEM is defined as an eosinophilic infiltration in the esophageal muscle layer but not in the mucosa as well as the presence of EoE-like symptoms, such as dysphagia, food impaction, and chest pain \[[@CR84], [@CR85]\]. EoEM is a rare disease but must be differentiated in cases with EoE symptoms in the absence of esophageal eosinophilia. EoEM is suspected by HRM findings (Jackhammer esophagus) and confirmed by histological examination of the esophageal muscular layer by per-oral endoscopic myotomy with biopsy (POEM-b) \[[@CR86]\] or endoscopic ultrasound-guided fine-needle aspiration biopsy \[[@CR87]\]. Recently, Spechler proposed an interesting hypothesis that the clinical manifestations are determined by the layers exhibiting eosinophilic infiltration. Furthermore, they showed the possibility that EoE has mucosal-predominant and muscle-predominant forms and that the muscle-predominant form of EoE can cause various esophageal motility disorders including achalasia \[[@CR88]\]. They also hypothesized that eosinophil infiltration in the esophageal mucosa could be found due to chronic contact of residue in patients with achalasia \[[@CR89]\]. Further studies regarding the association between EoE or EoEM and esophageal motility disorders are warranted.

Current treatment of EoE {#Sec14}
========================

The current treatment of EoE has briefly been outlined \[[@CR1]--[@CR3], [@CR6]--[@CR8], [@CR90], [@CR91]\], and it should be noted that the medications currently available for EoE have not been approved by medical insurance of the government in Japan. Because most cases of EoE in Japan are mild, PPI or P-CAB therapy is the first-line treatment; however, the doses and duration of these drugs remain to be clarified. In cases with improvement following PPI or P-CAB therapy, observation after therapy, intermittent therapy, on-demand therapy, or maintenance therapy are selected based on the severity of symptoms. Interestingly, this therapeutic strategy is similar to that of GERD treatment \[[@CR92]\]. In cases where PPI or P-CAB therapy does not improve symptoms, topical steroid therapy is required. Fluticasone or budesonide is commonly used for steroid swallowing, and a low dose of steroid swallowing can be used as maintenance therapy if necessary. Systemic corticosteroid therapy is limited to severe cases that require hospitalization. Furthermore, the six or four food elimination diet is an important fundamental treatment because specific allergens can be identified, although it is difficult to perform for adults. Moreover, in cases with strictures, endoscopic balloon dilation is safe and effective. The current treatment strategy is summarized in Fig. [6](#Fig6){ref-type="fig"} \[[@CR91]\].Fig. 6Current treatment strategy (*modified from reference no. 90*). \*Other treatments include montelukast, sodium cromoglicate, immunosuppressive drugs, and biologics. *PPI* proton pump inhibitor, *P-CAB* potassium competitive acid blocker, *SFED* six-food-elimination diet, *FFED* four-food-elimination diet, *ED* elemental diet

Conclusion and diagnostic approach {#Sec15}
==================================

This review has clarified the symptom variations and prevalence of EoE in Japanese adult patients and described several important considerations in the diagnosis of EoE. The review is summarized as a flowchart of the symptom-based diagnostic approach for EoE in Fig. [7](#Fig7){ref-type="fig"}.Fig. 7Symptom-based diagnostic approach for eosinophilic esophagitis. \*Case refractory to standard treatment; \*\*Refer to a high-volume center without biopsy; \*\*\*severe endoscopic findings or other reasons. *EGD* esophagogastroduodenoscopy, *BX* biopsy, *Eos* eosinophils, *GERD* gastroesophageal reflux disease, *EoE* eosinophilic esophagitis, *FGID* functional gastrointestinal disorder, *EoEM* eosinophilic esophageal myositis
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